基本信息:
- 专利标题: METHOD, COMPOSITION AND KIT FOR ANTIGENIC BINDING OF NORWALK-LIKE VIRUSES
- 专利标题(中):方法,组合物和用于抗病毒结合的病毒样病毒
- 申请号:PCT/US0317247 申请日:2003-06-02
- 公开(公告)号:WO03101176A2 公开(公告)日:2003-12-11
- 发明人: JIANG XI , LE PENDU JACQUES
- 申请人: CHILDRENS HOSP MEDICAL CENTER , JIANG XI , LE PENDU JACQUES
- 专利权人: CHILDRENS HOSP MEDICAL CENTER,JIANG XI,LE PENDU JACQUES
- 当前专利权人: CHILDRENS HOSP MEDICAL CENTER,JIANG XI,LE PENDU JACQUES
- 优先权: US38528302 2002-05-31; US38529602 2002-05-31
- 主分类号: A61K31/70
- IPC分类号: A61K31/70 ; C12N15/33 ; G01N33/569
摘要:
A method for detecting a Norwalk-Like Virus (NLV) in a biological sample, comprising the steps of: obtaining a biological sample suspected of containing a NLV; contacting the biological sample with at least one human histo-blood group antigen to allow formation of a complex of the NLV with the antigen; and detecting the antigen NLV complex. The antigen-NLV complex can be detected by contacting the NLV-antigen complex with a NLV antibody that binds at an epitope of the NLV, and detecting the NLV antibody. The invention also includes a method for identifying compounds, and the compounds, that can inhibit the binding between a Norwalk-Like Virus (NLV) and a histo-blood group antigen. The method includes the steps of contacting the NLV target with a compound; subsequently contacting the NLV with a standard compound that is known to be bound at a determinant binding site of the NLV; and determining whether the binding of the standard compound is decreased in the presence of the test compound, the decrease in binding being an indication that the test compound inhibits the binding activity of the NLV with the standard compound. In preferred embodiments, the standard compound is a histo-blood group antigen.
摘要(中):
一种用于在生物样品中检测诺瓦克样病毒(NLV)的方法,包括以下步骤:获得怀疑含有NLV的生物样品; 使所述生物样品与至少一种人组织血型抗原接触以允许形成所述NLV与所述抗原的复合物; 并检测抗原NLV复合物。 可以通过使NLV-抗原复合物与在NLV的表位结合的NLV抗体接触并检测NLV抗体来检测抗原-NOV复合物。 本发明还包括鉴定可以抑制诺沃克样病毒(NLV)和组织血型抗原之间的结合的化合物和化合物的方法。 该方法包括使NLV靶与化合物接触的步骤; 随后将NLV与已知结合在NLV的决定簇结合位点的标准化合物接触; 并测定在测试化合物存在下标准化合物的结合是否降低,结合的降低表明测试化合物抑制NLV与标准化合物的结合活性。 在优选的实施方案中,标准化合物是组织 - 血型抗原。
公开/授权文献:
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K31/00 | 含有机有效成分的医药配制品 |
--------A61K31/70 | .碳水化合物;糖;其衍生物 |